TRENTON, N.J.–(December 15)–BioNJ, New Jersey’s trade association for the biotechnology community, announced today that the fifth annual Dr. Sol J. Barer Award for Vision, Innovation, and Leadership has been awarded to Paul G. Thomas, Founder and CEO of Roka Bioscience. Named for Sol J. Barer, Ph.D., a Senior Advisor and former Chairman and CEO of Celgene Corporation of Summit, N.J., the award recognizes outstanding research and business leaders who have made significant contributions to the growth and prosperity of the biosciences industry in New Jersey and throughout the world. Read more »
New Jersey Governor Chris Christie to Address BioNJ 2012 Annual Meeting
TRENTON, NJ (November 16) – BioNJ, the trade association for New Jersey’s growing biotechnology industry, will welcome New Jersey Governor Chris Christie to address attendees at the association’s 2012 Annual Dinner Meeting, Awards Program and Networking Event on Thursday, February 2. The event will be held at the East Brunswick Hilton in East Brunswick, NJ beginning at 5:00 p.m. Read more »
Oncobiologics Ribbon Cutting Ceremony – October 14, 2011
Alfred Titone, District Director of the Small Business Administration; Dr. Pankaj Mohan, Oncobiologics Founder and CEO; Kim Guadagno, New Jersey Lt. Governor; Debbie Hart, BioNJ President; Robert Menendez, U.S. Senator; and Jeremy Caudill, Oncobiologics Vice President of Business Development, cut the ribbon at the grand opening at the company’s Cranbury facility. Photo courtesy of Lauren Rutten Photography. Read more »
High Profile Delegation of Life Sciences CEOs from Bordeaux Visits America’s Medicine Chest State
TRENTON, N.J.–(BUSINESS WIRE)–Chief Executive Officers (CEOs) representing eight flagship biotechnology and life science companies from Bordeaux, France, will visit New Jersey June 15-16 to engage in bilateral trade discussions with biotechnology and other life science companies located in the Garden State.
The delegation is supported by the Chamber of Commerce and Industry of Bordeaux, the Regional Council of Aquitaine, where Bordeaux is the capital, and GIPSO (le Groupement Interprofessionel de Pharmaceutiques et Sante du Sud Oest) and hosted by BioNJ, Choose New Jersey, the New Jersey Business Action Center and Princeton University. Read more »
BioNJ and Publicis Healthcare Communications Group Partner On Forum to Explore Complex Biosimilar Issues
New York, NY, June 6, 2011—As billions of biotech products are set to go off patent, Congress and industry look to biosimilar legislation to guide next steps. Publicis Healthcare Communications Group (PHCG) and BioNJ convened a panel of top industry experts to discuss “Biosimilars and Protecting R&D Dollars” on June 2, 2011 in Bridgewater, New Jersey. Read more »
BioNJ Webinar Focuses on the Future of Personalized Medicine
Industry Leaders Highlight the Role of Diagnostics in Enhancing the Value and Improving Outcomes for Therapeutics, Making Personalized Medicine a Reality
TRENTON, NJ (May 5, 2010)—The growing interrelationship between diagnostics and therapeutics to deliver improvements in patient outcomes, reduce overall healthcare costs and increase the productivity of drug discovery was addressed by leaders in diagnostics and personalized medicine in a webinar hosted at BioNJ, the voice of the biotechnology industry in New Jersey. Read more »
New Jersey among Top States under Qualifying Therapeutic Discovery Project
TRENTON, NJ (Nov. 3, 2010) – BioNJ President Debbie Hart issued the following statement today following the announcement by U.S. Treasury Secretary Timothy Geithner and Health and Human Services Secretary Kathleen Sebelius of the recipients of the $1 billion Therapeutic Discovery Project: Read more »
Employment at NJ Biotechnology Companies Growing
Employment at NJ Biotechnology Companies Growing
Industry Survey Sees 50 Percent Growth from 2007 to 2010
Access to Capital Remains Constrained
TRENTON, NJ (July 29, 2010) ─ The number of employees working at New Jersey biotechnology companies increased by 50 percent in the last three years, growing from 10,000 employees in 2007 to an estimated 15,000 in 2010, Read more »
New Jersey Biotechnology Continues to See Growth
Number of NJ Companies Continues to Increase in Latest Survey
Early-Stage Funding a Continuing Issue
TRENTON, NJ (June 10, 2010) ─ The number of biotechnology companies operating in New Jersey continues to increase significantly despite the downturn in the economy, ongoing difficulties in obtaining venture capital and other forms of funding and a contraction in the biotechnology and pharmaceutical industries at both the state and national levels, according to initial results from an industry survey released today by BioNJ, the trade association for the biotechnology industry in New Jersey. Read more »
BioNJ Holds New Jersey’s Only BioPartnering Conference on June 14-15 in Princeton
TRENTON, NJ (June 7, 2010) – BioNJ, New Jersey’s trade association for the biotechnology industry, will hold its 2010 BioPartnering Conference on June 14 and 15 at the Westin Princeton at Forrestal Village, in Princeton, NJ. Read more »
Greater Philadelphia Region Life Sciences Cluster Attains Top Rankings
A comparative study conducted by the Milken Institute ranks the Greater Philadelphia region second in the study’s Overall Composite Index, after only Boston and ahead of Greater San Francisco.
Read more »
BioNJ Welcomes New and Returning Members to the Board of Trustees
TRENTON (January 28, 2010) – At its 17th Annual Meeting on January 28, BioNJ’s Board of Trustees announced the appointment of three new board members, and reappointment of five board members. The mission of the Board is to help foster a positive culture for biotechnology companies to prosper in New Jersey. Read more »
BioNJ Presents Third Annual Dr. Sol J. Barer Award for Vision, Leadership to Lilly’s John Johnson
TRENTON, NJ – January 22, 2010 — BioNJ, New Jersey’s trade association for the biotechnology community, announced today that the third annual Dr. Sol J. Barer Award for Vision, Innovation and Leadership has been awarded to John H. Johnson, President of Global Oncology and Senior Vice President of Eli Lilly and Company. Read more »
Career Expo Draws 500 Professionals Looking for Work in the Biotechnology & Pharmaceutical Industries
NEW BRUNSWICK, June 17, 2011 – More than 500 professionals equipped with resumes and dressed for success showed up to meet employers looking to fill jobs in the state’s growing bio-technology, pharmaceutical and life sciences industries today.
The New Jersey Department of Labor and Workforce Development (LWD) teamed with the BioNJ Talent Network to host the free “Career Expo” held at the Student Center on the campus of Rutgers University in New Brunswick. Read more »
BioNJ Elects New Officers; Adds Five New Members to Board of Trustees
TRENTON (January 23, 2009) — BioNJ, New Jersey’s trade association for bioscience companies, announced today that at its January 22, 2009 Annual Meeting, Dinner and Awards Program the Board of Trustees named new officers and elected five new members. The mission of the Board is to help foster a positive culture for biotechnology companies to prosper in New Jersey. Read more »
BioNJ Presents 2nd Annual Dr. Sol J. Barer Award for Vision, Innovation and Leadership to Genmab CEO, Lisa N. Drakeman, Ph.D.
TRENTON (January 22, 2009) — BioNJ, New Jersey’s trade association for bioscience companies, announced today that the second annual Dr. Sol J. Barer Award for Vision, Innovation and Leadership had been awarded to Lisa N. Drakeman, Ph.D., who is Chief Executive Officer of Genmab of Princeton, NJ. Read more »
